Stock Events

Viking Therapeutics (0VQA.LSE) Q1 2024 Earnings

0VQA.LSE +4.61%
24AprConfirmed
Q1 2024
-0.28
-0.27
-0.27
-0.26

Details

Expected EPS
-0.27668
Actual EPS
-0.26
Surprise EPS
0.02
Surprise Percent
+6.03%

Description

Viking Therapeutics (0VQA.LSE) has reported earnings of -0.26 per share for Q1 2024.

0 Comments

Share your thoughts